Because TNF-pretreatment of pediatric sarcoma cell lines did not promote anti-tumor activity of unspecific PBMCs, we tested whether pretreatment with TNF sensitizes EwS cell lines to killing by antigen-specific CHM1319 CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.